UNSPSC 51351908: Norgestrienone

This classification denotes a therapeutic estrogen with the molecular formula C20H22O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 89386PYU9O, chemically known as 19-norpregna-4,9,11-trien-20-yn-3-one, 17-hydroxy-, (17-alpha)- (9ci) but generally known as norgestrienone, which bears US NIH Compound Identifier 13313. European Medicines Agency schedules Norgestrienone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09372MIG.

I cannot produce a summary of UNSPSC 51351908 Norgestrienone based on the source provided. The source contains only the code number and product name — there are no recent state and local contract opportunities, no issuing bodies, no geographic data, and no scope detail beyond the chemical name itself. Without the <most-recent-state-local-contract-opportunities> block populated with actual solicitation records, I have no factual basis to characterize what state and local governments are buying under this code, who is buying it, where they are located, or whether procurement activity exists at all.

To write a decision-relevant summary, I would need at least one recent RFP, RFQ, IFB, or ITB notice from a state agency, county, municipality, school district, transit authority, or other state/local body that names this code and describes the work or product being procured.